APTO - Aptose Biosciences Inc.
1.71
-1.440 -84.211%
Share volume: 670,384
Last Updated: 04-01-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.02%
PREVIOUS CLOSE
CHG
CHG%
$3.15
-1.44
-0.46%
View ratios
| Fiscal Date | 03-31-2023 | 06-30-2023 | 09-30-2023 | 12-31-2023 | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | |
| Report Date | 05-14-2024 | 08-10-2023 | 11-09-2023 | 11-09-2024 | 05-14-2024 | 08-08-2024 | 11-09-2024 | 03-28-2025 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | nan% | nan% | nan% | ||||
| Operating expenses | 14.096 M | 14.452 M | 11.681 M | 12.127 M | 9.760 M | 7.345 M | 6.965 M | 2.187 M | |
| Selling general and admin | 5.285 M | 3.870 M | 3.425 M | 3.011 M | 3.315 M | 2.932 M | 2.263 M | 2.644 M | |
| Research and development | 8.811 M | 10.582 M | 8.256 M | 9.116 M | 6.445 M | 4.413 M | 4.702 M | -457.000 K | |
| Total expenses | 14.096 M | 14.452 M | 11.681 M | 12.127 M | 9.760 M | 7.345 M | 6.965 M | 2.187 M | |
| 2.53% | -19.17% | 3.82% | -19.52% | -24.74% | -5.17% | -68.60% | |||
| Operating income | -14.096 M | -14.452 M | -11.681 M | -12.127 M | -9.760 M | -7.345 M | -6.965 M | -2.187 M | |
| Ebit | -14.098 M | -14.455 M | -11.679 M | -12.126 M | -9.761 M | -7.345 M | -6.965 M | -1.509 M | |
| Pretax income | -13.676 M | -14.129 M | -11.447 M | -11.955 M | -9.640 M | -7.252 M | -6.953 M | -1.378 M | |
| 3.31% | -18.98% | 4.44% | -19.36% | -24.77% | -4.12% | -80.18% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -13.676 M | -14.129 M | -11.447 M | -11.955 M | -9.640 M | -7.252 M | -6.953 M | -1.585 M | |
| -3.31% | 18.98% | -4.44% | 19.36% | 24.77% | 4.12% | 77.20% |
